Wilson Sonsini Goodrich & Rosati advised MBX Biosciences on the deal while WilmerHale advised Wellington Management. MBX Biosciences, Inc., a clinical stage biopharmaceutical company developing Precision...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here